A novel combination of promoter and enhancers increases transgene expression in vascular smooth muscle cells in vitro and coronary arteries in vivo after adenovirus-mediated gene transfer
Open Access
- 8 August 2003
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (18) , 1616-1622
- https://doi.org/10.1038/sj.gt.3302044
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Adenovirus-Mediated Gene Transfer of a Secreted Transforming Growth Factor-β Type II Receptor Inhibits Luminal Loss and Constrictive Remodeling After Coronary Angioplasty and Enhances Adventitial Collagen DepositionCirculation, 2001
- A Genetically Modified Adenoviral Vector Exhibits Enhanced Gene Transfer of Human Smooth Muscle CellsJournal of Vascular Research, 2001
- Improved Adenovirus Vectors for Infection of Cardiovascular TissuesJournal of Virology, 2001
- Gene Transfer into Neural Cells In Vitro Using Adenoviral VectorsCurrent Protocols in Neuroscience, 2000
- Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in VivoMolecular Therapy, 2000
- Optimizing Vascular Gene Transfer of Plasminogen Activator Inhibitor 1Human Gene Therapy, 1999
- Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.Journal of Clinical Investigation, 1997
- Optimal techniques for arterial gene transferCardiovascular Research, 1997
- Expression of the Smooth Muscle Myosin Heavy Chain Gene Is Regulated by a Negative-acting GC-rich Element Located between Two Positive-acting Serum Response Factor-binding ElementsPublished by Elsevier ,1997
- A Novel Smooth Muscle-specific Enhancer Regulates Transcription of the Smooth Muscle Myosin Heavy Chain Gene in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1995